Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKropz Plc Regulatory News (KRPZ)

Share Price Information for Kropz Plc (KRPZ)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.00 (0.00%)
Bid:
1.20
Ask:
1.30
Spread: 0.10 (8.333%)
Market Cap: £20.59m
KRPZ Live PriceLast checked at - London Stock Exchange

Intraday Kropz Plc Share Chart

Equity Facility Draw Down

9 Dec 2020 07:00

RNS Number : 9895H
Kropz PLC
09 December 2020
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

9 December 2020

Kropz Plc("Kropz" or the "Company")

Equity Facility Draw Down

Kropz Plc (AIM: KRPZ) is pleased to confirm that it has made its third quarterly draw down request under the equity facility with Kropz's major shareholder, the ARC Fund. The equity facility is for an amount of US$ 40 million (which cannot exceed ZAR 680 million) as announced on 13 May 2020 ("Equity Facility").

The third draw down is for US$ 5 million which will be paid by way of issue of 63,703,704 new ordinary shares at the issue price of 6.75 pence per ordinary share to the ARC Fund on 10 December 2020. The next draw down of the Equity Facility is expected to be made on or about 10 March 2021 and quarterly thereafter, in line with the terms of the Equity Facility.

The proceeds from the drawn down will be applied to the continuing workstreams at the Elandsfontein Phosphate Project. The Company will release a full operational update on progress in January 2021.

Admission and Total Voting Rights

 

Application will be made for the 63,703,704 new ordinary shares to admission to trading on the AIM Market of the London Stock Exchange ("AIM"). It is expected that admission will become effective and that dealings in the new ordinary shares will commence at 8.00 a.m. on 10 December 2020.

 

On Admission, the Company's issued share capital will consist of 558,627,558 ordinary shares with voting rights. There are no shares held in treasury. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Change in Shareholding

 

Following issue of the 63,703,704 of new ordinary shares, the ARC Fund will be directly interested in 409,948,665 ordinary shares of the Company representing 73.4 per cent. of the issued share capital.

 

In addition, the ARC Fund holds call options over certain shares held by Kropz International S.a.r.l as set out in the announcement on 13 May 2020.

 

For further information visit www.kropz.com or contact:

 

Kropz Plc

 

Mark Summers (CEO)

+27 (0)79744 8708

 

 

Grant Thornton UK LLP

Nominated Adviser

Samantha Harrison

Harrison Clarke

+44 (0) 20 7383 5100

 

 

Hannam & Partners

Broker

Andrew Chubb

Ernest Bell

 +44 (0)20 7907 8500

 

Tavistock

Financial PR & IR (UK)

Emily Moss

Jos Simson

Oliver Lamb

+44 (0) 207 920 3150

kropz@tavistock.co.uk

 

R&A Strategic Communications

PR (South Africa)

James Duncan

+27 (0)11 880 3924

james@rasc.co.za 

 

About Kropz Plc

Kropz is an emerging African phosphate explorer and developer, with an advanced stage phosphate project in South Africa and a phosphate project in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLAFSLTIII
Date   Source Headline
12th Feb 20203:23 pmRNSElandsfontein Update
6th Feb 20207:00 amRNSElandsfontein Update
18th Dec 20197:00 amRNSElandsfontein Update
11th Dec 20197:00 amRNSElandsfontein Update
25th Oct 20197:00 amRNSMemorandum of Understanding with PhosAgro
24th Oct 20197:00 amRNSElandsfontein Update
22nd Oct 20197:00 amRNSElandsfontein Update
26th Sep 20197:00 amRNSInterim Results for the Period ended 30 June 2019
12th Sep 20197:00 amRNSElandsfontein Update
26th Jul 201911:12 amRNSResult of Meeting
28th Jun 201911:49 amRNSResult of AGM
27th Jun 20194:30 pmRNSPlacing to Raise USD 4.34 Million
24th Jun 20197:00 amRNSFinal Results, Annual Report and Notice of GM
5th Jun 20197:00 amRNSTrading Update & Notice of Annual General Meeting
19th Feb 20197:00 amRNSUpdate on offer for Cominco, Issue of Shares & TVR
14th Feb 20197:00 amRNSAppointment of Elandsfontein MD
1st Feb 20197:00 amRNSIssue of Shares and Total Voting Rights
3rd Dec 20185:02 pmRNSUpdate on offer for Cominco Resources
30th Nov 20187:00 amRNSAdmission to Trading and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.